A Win For Lexicon Pharmaceuticals, Inc.
Fri, Mar 28, 2025 at 07:43 PM
Lexicon Pharmaceuticals, Inc. (LXRX:NASDAQ) soared at $0.57, a gain of 64.1%. On Fri, Mar 28, 2025, LXRX:NASDAQ touched a New 2-Week High of $0.57. The stock got featured on our News Catalysts scanner on Fri, Mar 28, 2025 at 09:43 AM in the 'AGREEMENT' category. From Fri, Mar 14, 2025, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Fri, Jan 24, 2025 at $1.09 with a volume of 6M+.
About Lexicon Pharmaceuticals, Inc. (LXRX:NASDAQ)
Lexicon Pharmaceuticals Inc operates as a biopharmaceutical company engaged in discovery and development of breakthrough treatments for human disease. The company mainly designs and develops drugs for therapeutic areas.
Top 10 Gainers:
- Sacks Parente Golf Inc. (SPGC:NASDAQ), 2042.86%
- Portage Biotech Inc. (PRTG:NASDAQ), 102.96%
- Lexicon Pharmaceuticals, Inc. (LXRX:NASDAQ), 64.13%
- DBV Technologies S.A. (DBVT:NASDAQ), 53.09%
- My Size, Inc. (MYSZ:NASDAQ), 42.06%
- Oriental Culture Holding LTD (OCG:NASDAQ), 33.33%
- Lixiang Education Holding Co. Ltd. (LXEH:NASDAQ), 32.41%
- Movella Holdings Inc Com (MVLA:NASDAQ), 25%
- OneConstruction Group Limited (ONEG:NASDAQ), 21.84%
- Alumis Inc. (ALMS:NASDAQ), 20%